13/09/2017 17:54:45

HIFU for Prostate Cancer now Available at North Carolina Specialty Hospital in Durham, North Carolina

CHARLOTTE, N.C., Sept. 13, 2017 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC, the leading provider of HIFU technology to physician practices in the United States, has partnered with North Carolina Specialty Hospital to offer HIFU (high intensity focused ultrasound) for prostate cancer at their state-of-the-art hospital in Durham, N.C.

“At North Carolina Specialty Hospital, we pride ourselves on providing exceptional patient care while exceeding our patient’s expectations for quality and satisfaction. We are excited to partner with HIFU Prostate Services to provide prostate cancer patients minimally-invasive options in our patient-centered facility,” said Joy Boyd, director of surgical services, North Carolina Specialty Hospital.

Frank Tortora, MD, treated the first prostate cancer patients with HIFU this week at North Carolina Specialty Hospital.  Michael Wolff, MD will begin treating patients next month.

HIFU uses ultrasound energy that is precisely focused to rapidly heat and destroy tissue in the prostate. Due to its accuracy and precision, areas around the prostate are undamaged which greatly reduces the risk of side effects. Earlier this summer, a Medicare code was issued by the Centers for Medicare and Medicaid Services that may help some patients cover part of the cost of the HIFU procedure.

"The most recent decision by Medicare to issue coverage for the facility charge for HIFU is a wonderful acknowledgement of the needs of men for a treatment that offers effective treatment of prostate cancer while maintaining a high quality of life,” said Tortora of Associated Urologists of North Carolina.  “I am proud of our ability to help men achieve a satisfactory solution to control the cancer but maintain their continence and sexual ability.”

“HIFU is now a more accessible and more affordable minimally-invasive prostate cancer treatment.  It has become a lower cost alternative to prostate cancer treatments such as surgery and radiation, that also carries less risk of side effects,” said Wolff of Alamance Urological.

Although HIFU is designed as a single treatment, it can be repeated if needed. HIFU may also be used to treat patients that have failed radiation therapy and it does not preclude any future treatments including surgery or radiation. HIFU offers patients an outpatient treatment that is bloodless and allows patients to return to their normal lifestyles within a few days after treatment. 

“We have always seen high demand from patients for HIFU. The more places that we can make the non-invasive prostate cancer procedure available, the more we can do to meet the demand of those patients,” said John McLean, chief operating officer, HIFU Prostate Services.

HIFU is already available at outpatient treatment facilities throughout the United States with the most experienced HIFU physicians in the country. To learn more about where HIFU is available, visit https://www.hifuprostateservices.com/treatment-locations.

About HIFU Prostate Services, LLC

HIFU Prostate Services was founded to provide men access to a less invasive treatment option for prostate cancer that has the ability to eliminate cancer and preserve patient quality of life. Our mission is to deliver the highest quality of care, support, and technology to the patient and to the urology community for the treatment of localized prostate cancer using Sonablate® HIFU. The company is headquartered in Charlotte, NC and with locations in 12 cities throughout the US. Learn more at http://www.hifuprostateservices.com.

About North Carolina Specialty Hospital

North Carolina Specialty Hospital is a physician owned surgical hospital that has been serving “The Triangle” since 1926. North Carolina Specialty Hospital’s state-of-the-art medical facility specializes in orthopedics, ophthalmology, ear, nose and throat as well as sports medicine, oral, plastic, podiatry, general, bariatric, interventional radiology, pain management, and reconstructive surgery.

Media Contact:

John Linn (704) 248-7562

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
16 May
 
Hej,   Jeg har været herinde i dette forum siden 2010, og har fulgt mange debatører, men en af dem s..
28
17 May
PNDORA
Jeg personligt mener at en stor del af skribenterne her på forum og markedet som helhed overreagerer..
17
16 May
PNDORA
Pandora dykkede fordi der manglede 60 millioner i omsætning ud af 1.500 millioner. Det er jo helt gr..
16
13 May
VWS
Det er interessant at læse lidt mere i dybden på GE's nye havvindmølle. Én ting er marketing, og spø..
15
19 May
PNDORA
Pandora realiserede i Q1 2018 en omsætning, som var 44 mDKK lavere end 1Q 2017, såfremt valutakurser..
14
17 May
NOVO-B
Trump fik fortalt at PBM'ernes rabatsystem er taget for fremskaffelse af lavere priser til patienter..
14
18 May
DANSKE
Kongsmart, Jensen og Pedersen var de 3 sidste kandidater til en højt betroet post i banken. De mangl..
13
15 May
VELO
Har lyttet til det nu. Ikke så meget nyt, men bider mærke i, at Envarsus bliver mere og mere en fast..
13
14 May
VELO
Nu begynder Veloxis at levere varen. Det er klart, at med en vækst 142% i omsætning i forhold til Q1..
13
14 May
NOVO-B
Nu vil jeg ikke bruge meget tid på dit "Sikken dog noget sludder"  udover, at det er klart, at du ik..
13

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
A10 NETWORKS DEADLINE ALERT: Rosen Law Firm Reminds A10 Networks, Inc. Investors of Important May 21 Deadline in First File Class Action– ATEN
2
8th Continent joins the Bancor decentralised liquidity network
3
Lambert Catches Record-Breaking Limit to Take Lead after Day Three of FLW Tour at Kentucky Lake Presented by Costa Sunglasses
4
Larson Electronics LLC Releases 10 Million Candlepower Rechargeable Handheld LED Spotlight
5
TheRecover.com, Columbus Drug Rehabs Can Help

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 May 2018 12:58:47
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180515.2 - EUROWEB4 - 2018-05-20 13:58:47 - 2018-05-20 12:58:47 - 1000 - Website: OKAY